1,338
Views
0
CrossRef citations to date
0
Altmetric
Research Article

BNIP3 overexpression may promote myeloma cell apoptosis by enhancing sensitivity to bortezomib via the p38 MAPK pathway

ORCID Icon, , , , , , & show all
Article: 2231739 | Received 24 May 2023, Accepted 27 Jun 2023, Published online: 04 Jul 2023

References

  • Toppila I, Kysenius K, Miettinen T, et al. Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005–2016. Ann Hematol. 2022;101(11):2485–2495. PMID:PMC9546994. doi:10.1007/s00277-022-04959-9
  • Pinto V, Bergantim R, Caires HR, et al. Multiple myeloma: available therapies and causes of drug resistance. Cancers (Basel). 2020;12(2):PMID:PMC7072128. doi:10.3390/cancers12020407
  • Mogollon P, Diaz-Tejedor A, Algarin EM, et al. Biological background of resistance to current standards of care in multiple myeloma. Cells. 2019;8(11):PMID:PMC6912619. doi:10.3390/cells8111432
  • Viziteu E, Klein B, Basbous J, et al. RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma. Leukemia. 2017;31(10):2104–2113. PMID:PMC5629372. doi:10.1038/leu.2017.54
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262
  • Jin Q, Li R, Hu N, et al. DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the Mff-required mitochondrial fission and Bnip3-related mitophagy via the JNK pathways. Redox Biol. 2018: 576–587. PMID:PMC5691221. doi:10.1016/j.redox.2017.11.004
  • Yuan C, Pu L, He Z, et al. BNIP3/Bcl-2-mediated apoptosis induced by cyclic tensile stretch in human cartilage endplate-derived stem cells. Exp Ther Med. 2017;15(1):235–241. PMID:PMC5763692. doi:10.3892/etm.2017.5372
  • Macher-Goeppinger S, Keith M, Hatiboglu G, et al. Expression and functional characterization of the BNIP3 protein in renal cell carcinomas. Transl Oncol. 2017;10(6):869–875. PMID:PMC5602480. doi:10.1016/j.tranon.2017.08.008
  • Chourasia AH, Tracy K, Frankenberger C, et al. Mitophagy defects arising from BNip3 loss promote mammary tumor progression to metastasis. EMBO Rep. 2015;16(9):1145–1163. PMID:PMC4576983. doi:10.15252/embr.201540759
  • Xu WL, Wang SH, Sun WB, et al. Insufficient radiofrequency ablation-induced autophagy contributes to the rapid progression of residual hepatocellular carcinoma through the HIF-1α/BNIP3 signaling pathway. BMB Rep. 2019;52(4):277–282. PMID:PMC6507849. doi:10.5483/BMBRep.2019.52.4.263
  • Niu Y, Lin Z, Wan A, et al. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer. 2019;18(1):46. PMID:PMC6437932. doi:10.1186/s12943-019-1004-4
  • Chourasia AH, Macleod KF. Tumor suppressor functions of BNIP3 and mitophagy. Autophagy. 2015;11(10):1937–1938. PMID:PMC4824596. doi:10.1080/15548627.2015.1085136
  • Blanquer-Rossello MM, Santandreu FM, Oliver J, et al. Leptin modulates mitochondrial function, dynamics and biogenesis in MCF-7 cells. J Cell Biochem. 2015;116(9):2039–2048. doi:10.1002/jcb.25158
  • Li J, Li Y, Jiao J, et al. Mitofusin 1 is negatively regulated by microRNA 140 in cardiomyocyte apoptosis. Mol Cell Biol (2014) 34(10):1788-1799. PMID:PMC4019028 doi:10.1128/MCB.00774-13
  • Choudhary V, Kaddour-Djebbar I, Alaisami R, et al. Mitofusin 1 degradation is induced by a disruptor of mitochondrial calcium homeostasis, CGP37157: a role in apoptosis in prostate cancer cells. Int J Oncol. 2014;44(5):1767–1773. doi:10.3892/ijo.2014.2343
  • Yu CL, Lee HL, Yang SF, et al. Protodioscin induces mitochondrial apoptosis of human hepatocellular carcinoma cells through eliciting ER stress-mediated IP3R targeting Mfn1/Bak expression.J Hepatocell Carcinoma. 2022: 327–341. PMID:PMC9049873. doi:10.2147/JHC.S355027
  • Cai J, Wang J, Huang Y, et al. ERK/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells. Cell Death Dis. 2016;7(11):e2459. PMID:PMC5260898. doi:10.1038/cddis.2016.370
  • Chung LY, Tang SJ, Wu YC, et al. Platinum-based combination chemotherapy triggers cancer cell death through induction of BNIP3 and ROS, but not autophagy. J Cell Mol Med. 2020;24(2):1993–2003. PMID:PMC6991685. doi:10.1111/jcmm.14898
  • Renaudin X. International review of cell and molecular biology. Int Rev Cell Mol Biol. 2021: 139–161. doi:10.1016/bs.ircmb.2021.04.001
  • Caillot M, Zylbersztejn F, Maitre E, et al. ROS overproduction sensitises myeloma cells to bortezomib-induced apoptosis and alleviates tumour microenvironment-mediated cell resistance. Cells. 2020;9(11):PMID:PMC7693395. doi:10.3390/cells9112357
  • Yin L, Kufe T, Avigan D, et al. Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death. Blood. 2014;123(19):2997–3006. PMID:PMC4014842. doi:10.1182/blood-2013-11-539395
  • Jia J, Yang X, Zhao Q, et al. BNIP3 contributes to cisplatin-induced apoptosis in ovarian cancer cells. FEBS Open Bio. 2020;10(8):1463–1473. PMID:PMC7396446. doi:10.1002/2211-5463.12881
  • Nollet EA, Cardo-Vila M, Ganguly SS, et al. Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer. Oncogene. 2020;39(31):5390–5404. PMID:PMC7395876. doi:10.1038/s41388-020-1370-9
  • Martinez MA, Ubeda A, Trillo MA. Role of NADPH oxidase in MAPK signaling activation by a 50 Hz magnetic field in human neuroblastoma cells. Electromagn Biol Med. 2021;40(1):103–116. doi:10.1080/15368378.2020.1851250
  • Cao X, Fu M, Bi R, et al. Cadmium induced BEAS-2B cells apoptosis and mitochondria damage via MAPK signaling pathway. Chemosphere. 2021: 128346. doi:10.1016/j.chemosphere.2020.128346
  • Sun J, Nan G. The mitogen-activated protein kinase (MAPK) signaling pathway as a discovery target in stroke. J Mol Neurosci. 2016;59(1):90–98. doi:10.1007/s12031-016-0717-8
  • Hsieh CJ, Kuo PL, Hsu YC, et al. Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation. Free Radical Biol Med. 2014: 159–170. doi:10.1016/j.freeradbiomed.2013.10.004
  • Huang C, Zhou T, Ma L, et al. IFI6 downregulation reverses oxaliplatin resistance of colorectal cancer cells by activating the ROS-induced p38MAPK signaling pathway. Biol Pharm Bull. 2023;46(1):26–34. doi:10.1248/bpb.b22-00439.